Your browser doesn't support javascript.
loading
Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes.
Bertoldi, Giovanni; Ravarotto, Verdiana; Sgarabotto, Luca; Davis, Paul A; Gobbi, Laura; Calò, Lorenzo A.
  • Bertoldi G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Ravarotto V; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Sgarabotto L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Davis PA; Department of Nutrition, University of California, Davis, California, USA.
  • Gobbi L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Calò LA; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
J Intern Med ; 291(4): 522-524, 2022 04.
Article en En | MEDLINE | ID: mdl-34875124
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Bartter / Enzima Convertidora de Angiotensina 2 / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Bartter / Enzima Convertidora de Angiotensina 2 / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article